Science: Alzheimers Disease
Parallel research from NIH highlights that chromatin organization shifts with aging and in Alzheimer’s disease, suggesting epigenetic remodeling contributes to disease progression. The study, published in *Nature Neuroscience* (May 2024), found that altered nucleosome positioning correlates with impaired neuronal gene expression.
Meanwhile, a New Scientist‑reported approach using engineered nanoparticles to re‑program glial cells into functional neurons offers a promising therapeutic strategy. In mouse models, nanoparticle‑mediated delivery of neurogenic factors restored synaptic connectivity and reduced plaque burden, demonstrating a potential pathway toward disease modification.
National Institutes of Health (NIH) | (.gov)